Rating History for Maze Therapeutics (MAZE) by Raymond James

More Stocks Rated by Raymond James | Latest Ratings for MAZE
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/13/2025 Martin Auster New Coverage Outperform
(N/A)		 48.00
(N/A)		 32.56
(44.83)		 37.68% Details